| The release and trans-synaptic transmission of Tau via exosomes Y Wang, V Balaji, S Kaniyappan, L Krüger, S Irsen, K Tepper, ... Molecular neurodegeneration 12, 1-25, 2017 | 675 | 2017 |
| Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability S Kaniyappan, RR Chandupatla, EM Mandelkow, E Mandelkow Alzheimer's & Dementia 13 (11), 1270-1291, 2017 | 87 | 2017 |
| FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments S Kaniyappan, K Tepper, J Biernat, RR Chandupatla, S Hübschmann, ... Molecular neurodegeneration 15, 1-16, 2020 | 52 | 2020 |
| Potent Tau aggregation inhibitor D‐peptides selected against Tau‐repeat 2 using mirror image phage display M Malhis, S Kaniyappan, I Aillaud, RR Chandupatla, LM Ramirez, ... ChemBioChem 22 (21), 3049-3059, 2021 | 28 | 2021 |
| Novel antibody against low‐n oligomers of tau protein promotes clearance of tau in cells via lysosomes RR Chandupatla, A Flatley, R Feederle, EM Mandelkow, S Kaniyappan Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020 | 23 | 2020 |
| A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro I Aillaud, S Kaniyappan, RR Chandupatla, LM Ramirez, S Alkhashrom, ... Alzheimer's Research & Therapy 14 (1), 15, 2022 | 17 | 2022 |
| Suppressing tau aggregation and toxicity by an anti-aggregant tau fragment GJ Pir, B Choudhary, S Kaniyappan, RR Chandupatla, E Mandelkow, ... Molecular neurobiology 56, 3751-3767, 2019 | 17 | 2019 |
| Purification and characterization of low-n tau oligomers S Kaniyappan, RR Chandupatla, E Mandelkow Amyloid Proteins: Methods and Protocols, 99-111, 2018 | 3 | 2018 |
| Development of D‐enantiomeric peptides as tau aggregation inhibitors directed against the hexapeptide motif PHF6* of tau SA Funke, M Malhis, S Kaniyappan, I Aillaud, RR Chandupatla, ... Alzheimer's & Dementia 17, e051591, 2021 | | 2021 |
